UniProt ID | ATM_MOUSE | |
---|---|---|
UniProt AC | Q62388 | |
Protein Name | Serine-protein kinase ATM | |
Gene Name | Atm | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 3066 | |
Subcellular Localization | Nucleus . Cytoplasmic vesicle . Primarily nuclear. Found also in endocytic vesicles in association with beta-adaptin. | |
Protein Description | Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FANCD2, NFKBIA, BRCA1, CTIP, nibrin (NBN), TERF1, RAD9 and DCLRE1C. May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Binds DNA ends. Plays a role in replication-dependent histone mRNA degradation. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation. Phosphorylates ATF2 which stimulates its function in DNA damage response.. | |
Protein Sequence | MSLALNDLLICCRQLEHDRATERRKEVDKFKRLIQDPETVQHLDRHSDSKQGKYLNWDAVFRFLQKYIQKEMESLRTAKSNVSATTQSSRQKKMQEISSLVRYFIKCANKRAPRLKCQDLLNYVMDTVKDSSNGLTYGADCSNILLKDILSVRKYWCEVSQQQWLELFSLYFRLYLKPSQDINRVLVARIIHAVTRGCCSQTDGLPSKFLDLFSKAIQYARQEKSSPGLSHILAALNIFLKSLAVNFRKRVCEAGDEILPTLLYIWTQHRLNDSLKEVIIELIQLQIYIHHPQGARAPEEGAYESMKWKSILYNLYDLLVNEISHIGSRGKYSSGSRNIAVKENLIDLMADICYQLFDADTRSVEISQSYVTQRESTDYSVPCKRRKIDVGWEVIKDYLQKSQSDFDLVPWLQITTRLISKYPSSLPNCELSPLILILYQLLPQQRRGERIPYVLRCLKEVALCQGKKSNLESSQKSDLLKLWIKIWSITFRGISSGQTQTENFGLLEAIIQGSLVELDREFWKLFTGSACKPSSPSVCCLTLALSICVVPDAIKMGTEQSVCEANRSFSVKESIMRWLLFYQLEDDLEDSTELPPILQSNFPHLVVEKILVSLTMKNSKAAMKFFQSVPECEQHCEDKEEPSFSEVEELFLQTTFDKMDFLTTVKEYAVEKFQSSVGFSVQQNLKESLDHYLLGLSEQLLSNYSSEITSSETLVRCSSLLVGVLGCYCYMGIITEDEAHKSELFQKAKSLMQCAGESISLFKNKTNEESRIGSLRNVMHLCTSCLCIHTKHTPNKIASGFFLRLLTSKLMNDIADICKSLASCTKKPLDHGVHPGEDDEDGGGCDSLMEAEGPSSTGLSTAYPASSVSDANDYGENQNAVGAMSPLAADYLSKQDHLLLDMLRFLGRSVTASQSHTVSFRGADIRRKLLLLLDSSILDLMKPLHLHMYLVLLKDLPGNEHSLPMEDVVELLQPLSLVCSLHRRDQDVCKTILSNVLHIVTNLGQGSVDMESTRIAQGHFLTVMGAFWHLTKEKKCVFSVRMALVKCLQTLLEADPYSEWAILNVKGQDFPVNEAFSQFLADDHHQVRMLAAGSVNRLFQDMRQGDFSRSLKALPLKFQQTSFNNAYTTAEAGIRGLLCDSQNPDLLDEIYNRKSVLLMMIAVVLHCSPVCEKQALFALCKSVKENRLEPHLVKKVLEKVSESFGCRSLEDFMISHLDYLVLEWLNLQDTEYSLSSFPFMLLNYTSIEDFYRSCYKILIPHLVIRSHFDEVKSIANQIQKCWKSLLVDCFPKILVHILPYFAYEGTRDSYVSQKRETATKVYDTLKGEDFLGKQIDQVFISNLPEIVVELLMTLHETADSADSDASQSATALCDFSGDLDPAPNPPYFPSHVIQATFAYISNCHKTKFKSILEILSKIPDSYQKILLAICEQAAETNNVFKKHRILKIYHLFVSLLLKDIQSGLGGAWAFVLRDVIYTLIHYINKRSSHFTDVSLRSFSLCCDLLSRVCHTAVTQCKDALESHLHVIVGTLIPLVDYQEVQEQVLDLLKYLVIDNKDNKNLSVTIKLLDPFPDHVIFKDLRLTQQKIKYSGGPFSLLEEINHFLSVSAYNPLPLTRLEGLKDLRRQLEQHKDQMLDLLRASQDNPQDGIVVKLVVSLLQLSKMAVNQTGEREVLEAVGRCLGEIGPLDFSTIAVQHNKDVSYTKAYGLPEDRELQWTLIMLTALNNTLVEDSVKIRSAAATCLKNILATKIGHIFWENYKTSADPMLTYLQPFRTSRKKFLEVPRSVKEDVLEGLDAVNLWVPQSESHDIWIKTLTCAFLDSGGINSEILQLLKPMCEVKTDFCQMLLPYLIHDVLLQDTHESWRTLLSAHVRGFFTSCFKHSSQASRSATPANSDSESENFLRCCLDKKSQRTMLAVVDYLRRQKRPSSGTAFDDAFWLDLNYLEVAKVAQSCSAHFTALLYAEIYSDKKSTDEQEKRSPTFEEGSQGTTISSLSEKSKEETGISLQDLLLEIYRSIGEPDSLYGCGGGKMLQPLTRIRTYEHEATWEKALVTYDLETSISSSTRQSGIIQALQNLGLSHILSVYLKGLDYERREWCAELQELRYQAAWRNMQWGLCASAGQEVEGTSYHESLYNALQCLRNREFSTFYESLRYASLFRVKEVEELSKGSLESVYSLYPTLSRLQAIGELENSGELFSRSVTDRERSEAYWKWQKHSQLLKDSDFSFQEPLMALRTVILETLVQKEMERSQGACSKDILTKHLVEFSVLARTFKNTQLPERAIFKIKQYNSAICGISEWHLEEAQVFWAKKEQSLALSILKQMIKKLDSSFKDKENDAGLKVIYAECLRVCGSWLAETCLENPAVIMQTYLEKAVKVAGSYDGNSRELRNGQMKAFLSLARFSDTQYQRIENYMKSSEFENKQTLLKRAKEEVGLLREHKIQTNRYTVKVQRELELDECALRALREDRKRFLCKAVENYINCLLSGEEHDLWVFRLCSLWLENSGVSEVNGMMKKDGMKISSYKFLPLMYQLAARMGTKMTGGLGFHEVLNNLISRISLDHPHHTLFIILALANANKDEFLSKPETTRRSRITKSTSKENSHLDEDRTEAATRIIHSIRSKRCKMVKDMEALCDAYIILANMDASQWRAQRKGINIPANQPITKLKNLEDVVVPTMEIKVDPTGEYENLVTIKSFKTEFRLAGGLNLPKIIDCVGSDGKERRQLVKGRDDLRQDAVMQQVFQMCNTLLQRNTETRKRKLTICTYKVVPLSQRSGVLEWCTGTVPIGEYLVNSEDGAHRRYRPNDFSANQCQKKMMEVQKKSFEEKYDTFMTICQNFEPVFRYFCMEKFLDPAVWFEKRLAYTRSVATSSIVGYILGLGDRHVQNILINEQSAELVHIDLGVAFEQGKILPTPETVPFRLSRDIVDGMGITGVEGVFRRCCEKTMEVMRSSQETLLTIVEVLLYDPLFDWTMNPLKALYLQQRPEDESDLHSTPNADDQECKQSLSDTDQSFNKVAERVLMRLQEKLKGVEEGTVLSVGGQVNLLIQQAMDPKNLSRLFPGWKAWV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSLALNDLL ------CCHHHHHHH | 33.38 | - | |
367 | Phosphorylation | DTRSVEISQSYVTQR CCCEEEEEHHHCCCC | 10.28 | 22817900 | |
770 | Phosphorylation | KNKTNEESRIGSLRN CCCCCCHHHHHHHHH | 24.02 | 30482847 | |
774 | Phosphorylation | NEESRIGSLRNVMHL CCHHHHHHHHHHHHH | 23.06 | 30482847 | |
913 | Phosphorylation | LGRSVTASQSHTVSF HCCCCCCCCCCCEEE | 23.89 | 28285833 | |
919 | Phosphorylation | ASQSHTVSFRGADIR CCCCCCEEECCHHHH | 15.47 | 28285833 | |
1326 | Ubiquitination | TKVYDTLKGEDFLGK HHHHHHHCCCCCCCC | 63.45 | 22790023 | |
1370 | Phosphorylation | SDASQSATALCDFSG CCHHHHHHHHCCCCC | 25.96 | - | |
1421 | Phosphorylation | ILSKIPDSYQKILLA HHHCCCHHHHHHHHH | 24.90 | 20139300 | |
1422 | Phosphorylation | LSKIPDSYQKILLAI HHCCCHHHHHHHHHH | 22.62 | 20139300 | |
1449 | Phosphorylation | KHRILKIYHLFVSLL HHHHHHHHHHHHHHH | 7.29 | 23926118 | |
1487 | Phosphorylation | IHYINKRSSHFTDVS HHHHHHCCCCCCCCC | 29.76 | 26026062 | |
1494 | Phosphorylation | SSHFTDVSLRSFSLC CCCCCCCCHHHHHHH | 22.37 | 26026062 | |
1727 | Phosphorylation | MLTALNNTLVEDSVK HHHHHCCCCCCCCHH | 30.98 | 26239621 | |
1887 | Phosphorylation | FKHSSQASRSATPAN HHCCHHHHHCCCCCC | 21.09 | 25338131 | |
1889 | Phosphorylation | HSSQASRSATPANSD CCHHHHHCCCCCCCC | 33.72 | 24704852 | |
1891 | Phosphorylation | SQASRSATPANSDSE HHHHHCCCCCCCCCC | 24.95 | 23429704 | |
1895 | Phosphorylation | RSATPANSDSESENF HCCCCCCCCCCCHHH | 44.62 | 29472430 | |
1897 | Phosphorylation | ATPANSDSESENFLR CCCCCCCCCCHHHHH | 42.73 | 23429704 | |
1899 | Phosphorylation | PANSDSESENFLRCC CCCCCCCCHHHHHHH | 41.62 | 23429704 | |
1980 | Phosphorylation | TDEQEKRSPTFEEGS CCCHHHCCCCCCCCC | 39.08 | 28833060 | |
1982 | Phosphorylation | EQEKRSPTFEEGSQG CHHHCCCCCCCCCCC | 44.95 | 28833060 | |
1987 | Phosphorylation | SPTFEEGSQGTTISS CCCCCCCCCCCCHHH | 28.81 | 22322096 | |
1990 | Phosphorylation | FEEGSQGTTISSLSE CCCCCCCCCHHHHCH | 17.20 | 28833060 | |
1991 | Phosphorylation | EEGSQGTTISSLSEK CCCCCCCCHHHHCHH | 26.20 | 28833060 | |
1993 | Phosphorylation | GSQGTTISSLSEKSK CCCCCCHHHHCHHCH | 24.12 | 28833060 | |
1994 | Phosphorylation | SQGTTISSLSEKSKE CCCCCHHHHCHHCHH | 31.87 | 28833060 | |
1996 | Phosphorylation | GTTISSLSEKSKEET CCCHHHHCHHCHHHH | 44.95 | 28833060 | |
2820 | Acetylation | KKMMEVQKKSFEEKY HHHHHHHHHHHHHHH | 56.41 | 23576753 | |
2821 | Acetylation | KMMEVQKKSFEEKYD HHHHHHHHHHHHHHH | 43.20 | 23576753 | |
3004 | Phosphorylation | DDQECKQSLSDTDQS CHHHHHHHHCHHHHH | 18.48 | 29550500 | |
3006 | Phosphorylation | QECKQSLSDTDQSFN HHHHHHHCHHHHHHH | 43.65 | 21149446 | |
3008 | Phosphorylation | CKQSLSDTDQSFNKV HHHHHCHHHHHHHHH | 32.34 | 29550500 | |
3026 | Acetylation | VLMRLQEKLKGVEEG HHHHHHHHHCCCCCC | 42.40 | - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATM_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
H2AX_MOUSE | H2afx | physical | 11571274 | |
DCAF6_HUMAN | DCAF6 | physical | 20360068 | |
LMNB1_HUMAN | LMNB1 | physical | 20360068 | |
CUL4A_HUMAN | CUL4A | physical | 20360068 | |
ATM_HUMAN | ATM | physical | 20360068 | |
DDB1_HUMAN | DDB1 | physical | 20360068 | |
DCAF8_HUMAN | DCAF8 | physical | 20360068 | |
2AAA_MOUSE | Ppp2r1a | physical | 22466704 | |
DNMT1_MOUSE | Dnmt1 | physical | 23754744 | |
KAT5_MOUSE | Kat5 | physical | 23754744 | |
UHRF1_MOUSE | Uhrf1 | physical | 23754744 | |
P53_MOUSE | Trp53 | physical | 21706008 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Multiple autophosphorylation sites are dispensable for murine ATMactivation in vivo."; Daniel J.A., Pellegrini M., Lee J.H., Paull T.T., Feigenbaum L.,Nussenzweig A.; J. Cell Biol. 183:777-783(2008). Cited for: AUTOPHOSPHORYLATION AT SER-367; SER-1899 AND SER-1987, FUNCTION, ANDMUTAGENESIS OF SER-367; SER-1899 AND SER-1987. |